DE60136087D1 - Transdermales verabreichungssystem mit individueller dosierung - Google Patents
Transdermales verabreichungssystem mit individueller dosierungInfo
- Publication number
- DE60136087D1 DE60136087D1 DE60136087T DE60136087T DE60136087D1 DE 60136087 D1 DE60136087 D1 DE 60136087D1 DE 60136087 T DE60136087 T DE 60136087T DE 60136087 T DE60136087 T DE 60136087T DE 60136087 D1 DE60136087 D1 DE 60136087D1
- Authority
- DE
- Germany
- Prior art keywords
- therapeutic agent
- patch
- dosage
- titratable
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/714,604 US6682757B1 (en) | 2000-11-16 | 2000-11-16 | Titratable dosage transdermal delivery system |
PCT/US2001/051197 WO2002041878A2 (en) | 2000-11-16 | 2001-11-13 | Titratable dosage transdermal delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60136087D1 true DE60136087D1 (de) | 2008-11-20 |
Family
ID=24870722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60136087T Expired - Lifetime DE60136087D1 (de) | 2000-11-16 | 2001-11-13 | Transdermales verabreichungssystem mit individueller dosierung |
Country Status (11)
Country | Link |
---|---|
US (4) | US6682757B1 (de) |
EP (3) | EP2269595B1 (de) |
JP (4) | JP5021150B2 (de) |
AT (1) | ATE410153T1 (de) |
AU (1) | AU2002241792A1 (de) |
CY (2) | CY1108687T1 (de) |
DE (1) | DE60136087D1 (de) |
DK (2) | DK1333818T3 (de) |
ES (2) | ES2313995T3 (de) |
PT (2) | PT1333818E (de) |
WO (1) | WO2002041878A2 (de) |
Families Citing this family (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
EP1304134A4 (de) * | 2000-06-30 | 2006-08-23 | Hisamitsu Pharmaceutical Co | Hilfsvorrichtung zum aufbringen eines klebemittels |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
WO2003014247A1 (en) * | 2001-08-10 | 2003-02-20 | Cosmed. Co., Ltd. | Pressure-sensitive adhesive for the skin and tapes or sheets for the skin made by using the same |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US20050118245A1 (en) * | 2002-03-27 | 2005-06-02 | Wilsmann Klaus M. | Assembled unit consisting of individually separable, transdermal, therapeutic systems |
DE10213772A1 (de) * | 2002-03-27 | 2003-10-09 | Gruenenthal Gmbh | Zusammenhängende Einheit aus vereinzelbaren transdermalen therapeutischen Systemen |
US20040033255A1 (en) * | 2002-06-10 | 2004-02-19 | Baker Carl J. | Transdermal delivery device disposal system |
WO2004000263A1 (en) | 2002-06-25 | 2003-12-31 | Acrux Dds Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
BRPI0409945A (pt) * | 2003-04-30 | 2006-04-25 | Purdue Pharma Lp | forma de dosagem resistente à alteração |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
NL1024933C2 (nl) * | 2003-12-03 | 2005-06-06 | Visker Beheer B V | Werkwijze voor het aanbrengen van een gebonden deklaag op een ondergrond, werkwijze voor het vervaardigen van een bekledingspakket en een bekledingspakket. |
WO2005084255A2 (en) * | 2004-02-27 | 2005-09-15 | Keith Alec D | Aspirin transdermal patch |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7951124B2 (en) * | 2004-04-13 | 2011-05-31 | Boehringer Technologies, Lp | Growth stimulating wound dressing with improved contact surfaces |
US7884258B2 (en) * | 2004-04-13 | 2011-02-08 | Boehringer Technologies, L.P. | Wound contact device |
DE102004020463A1 (de) * | 2004-04-26 | 2005-11-10 | Grünenthal GmbH | Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
US20050245852A1 (en) * | 2004-04-30 | 2005-11-03 | Ellefson Kimberly L | System and method for providing therapy to an area of a body |
US20060029654A1 (en) * | 2004-08-04 | 2006-02-09 | Cassel R D | Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain |
DE102004039728A1 (de) * | 2004-08-16 | 2006-02-23 | Beiersdorf Ag | Wirkstoffhaltiges Tape zur Behandlung von Gelenkerkrankungen |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
US20060079514A1 (en) * | 2004-10-13 | 2006-04-13 | Victory Pharma Incorporated | Methods and compositions including methscopolamine bromide |
US20060079513A1 (en) * | 2004-10-13 | 2006-04-13 | Preston David M | Methods and compositions including methscopolamine nitrate |
US8435944B2 (en) | 2005-06-03 | 2013-05-07 | Acrux Dds Pty Ltd. | Method and composition for transdermal drug delivery |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
US20090062909A1 (en) | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
DE202005014347U1 (de) * | 2005-09-09 | 2007-01-18 | Grünenthal GmbH | Applikationssystem für ein wirkstoffhaltiges Pflaster und Wirkstoffabgaberegulierungsmittel |
US20070092571A1 (en) * | 2005-10-25 | 2007-04-26 | Schur Henry B | Non-irritating formulation and method for the intradermal delivery of substances |
JP2009519246A (ja) * | 2005-12-08 | 2009-05-14 | フェルティン ファルマ | 経皮タバコアルカロイドパッチ |
US7740879B2 (en) * | 2006-01-17 | 2010-06-22 | Harrogate Holdings | Abuse resistant transdermal drug delivery patch |
DE102006011340A1 (de) * | 2006-03-09 | 2007-09-20 | Grünenthal GmbH | Wirkstoffhaltige Pflaster mit verbesserter Handhabung |
US20080000798A1 (en) * | 2006-03-20 | 2008-01-03 | Werner Gutmann | Dose packaging system for load-dose titration administration of a liquid formulation |
MX2008012265A (es) * | 2006-03-24 | 2009-02-20 | Auxilium Int Holdings Inc | Procedimiento para la preparacion de un laminado extruido por fusion en caliente. |
CA2932389A1 (en) | 2006-03-24 | 2007-10-04 | Auxilium International Holdings, Inc. | Stabilized compositions containing alkaline labile drugs |
ES2540059T3 (es) * | 2006-04-26 | 2015-07-08 | Micell Technologies, Inc. | Recubrimientos que contienen múltiples fármacos |
WO2008052000A2 (en) * | 2006-10-23 | 2008-05-02 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
DE102006054731B4 (de) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
US9737642B2 (en) * | 2007-01-08 | 2017-08-22 | Micell Technologies, Inc. | Stents having biodegradable layers |
MX2009007366A (es) | 2007-01-11 | 2009-07-16 | Acrux Dds Pty Ltd | Implemento para untar. |
EA020509B1 (ru) * | 2007-04-17 | 2014-11-28 | Миселл Текнолоджиз, Инк. | Стенты с биоразлагаемыми слоями |
WO2008148013A1 (en) | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
WO2009009651A1 (en) * | 2007-07-10 | 2009-01-15 | Agile Therapeutics, Inc. | Dermal delivery device with ultrasonic weld |
CA2692884C (en) * | 2007-07-10 | 2016-09-20 | Agile Therapeutics, Inc. | Dermal delivery device with in situ seal |
JP2010536445A (ja) * | 2007-08-21 | 2010-12-02 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮治療パッチのマルチトラック製作方法 |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
SG192524A1 (en) * | 2008-04-17 | 2013-08-30 | Micell Technologies Inc | Stents having bioabsorbable layers |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
RU2497679C2 (ru) * | 2008-10-02 | 2013-11-10 | Милан Инк. | Способ получения многослойного клеящегося ламинированного материала |
US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
GB0902368D0 (en) | 2009-02-13 | 2009-04-01 | Smith & Nephew | Wound packing |
EP2411083A4 (de) | 2009-03-23 | 2013-11-13 | Micell Technologies Inc | Medizinische wirkstofffreisetzungsvorrichtung |
EP2410954A4 (de) * | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | Periphere stents mit schichten |
US9981072B2 (en) * | 2009-04-01 | 2018-05-29 | Micell Technologies, Inc. | Coated stents |
CA2759015C (en) | 2009-04-17 | 2017-06-20 | James B. Mcclain | Stents having controlled elution |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
WO2011097103A1 (en) * | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8791315B2 (en) | 2010-02-26 | 2014-07-29 | Smith & Nephew, Inc. | Systems and methods for using negative pressure wound therapy to manage open abdominal wounds |
PL2552245T3 (pl) | 2010-03-26 | 2019-05-31 | Philip Morris Products Sa | Inhibicja podrażnienia sensorycznego podczas konsumpcji produktów tytoniowych niepalnych |
US8795762B2 (en) * | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
AU2016259348B9 (en) * | 2010-04-13 | 2018-11-29 | Relmada Therapeutics, Inc. | Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use |
KR101955175B1 (ko) | 2010-04-13 | 2019-03-06 | 나지브 바불 | 1-메틸-2'-6'-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법 |
EP2560576B1 (de) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents und andere vorrichtungen mit beschichtung durch eine extrazelluläre matrix |
USD692565S1 (en) | 2010-06-03 | 2013-10-29 | Smith & Nephew, Inc. | Organ protection layer |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
CA2815568C (en) * | 2010-09-23 | 2018-10-09 | Monosolrx Llc | Method and system for forming a pharmaceutical product directly onto a packaging surface |
CA140189S (en) | 2010-10-15 | 2011-11-07 | Smith & Nephew | Medical dressing |
CA140188S (en) | 2010-10-15 | 2011-11-07 | Smith & Nephew | Medical dressing |
US9861590B2 (en) * | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
WO2013012689A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
JP6285866B2 (ja) | 2011-11-23 | 2018-02-28 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然複合ホルモン補充製剤および療法 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PE20142341A1 (es) | 2011-12-12 | 2015-01-17 | Lohmann Therapie Syst Lts | Sistema de administracion transdermica |
DE102013000723A1 (de) | 2012-01-17 | 2013-07-18 | Jens Messerschmidt | Verfahren und Pflaster zur Versorgung kleiner Verletzungen und/oder akuter Veränderungen der Haut oder von Hautanhangsgebilden, Verfahren zur Herstellung und Aufbringung eines solchen Pflasters und Verfahren zur Verwendung von Kalzium Kaseinat |
ES2663412T3 (es) * | 2012-01-31 | 2018-04-12 | Grünenthal GmbH | Parche farmacéutico para la administración transdérmica de (1R,4R)-6'-fluor-N,N-dimetil-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4-b]indol]-4-amina |
WO2013138520A1 (en) * | 2012-03-13 | 2013-09-19 | University Of Tennessee Research Foundation | Composition and system for transdermal delivery |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
ITMI20121428A1 (it) * | 2012-08-10 | 2014-02-11 | Allergosystem S R L | Dispositivo per applicazione topica di medicamenti o cosmetici |
US20150104495A1 (en) * | 2012-10-25 | 2015-04-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine |
US20140142522A1 (en) * | 2012-11-16 | 2014-05-22 | NU Technology, LLC | Moist dressing with honeycomb pattern and drain channels |
TW201431570A (zh) * | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
US20140170593A1 (en) * | 2012-12-18 | 2014-06-19 | Oltuse, Llc | Patch for non-invasive pain relief |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2014165264A1 (en) | 2013-03-12 | 2014-10-09 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US10335378B2 (en) | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
EP2996629B1 (de) | 2013-05-15 | 2021-09-22 | Micell Technologies, Inc. | Bioabsorbierbare biomedizinische implantate |
AP2015008920A0 (en) | 2013-06-04 | 2015-12-31 | Lohmann Therapie Syst Lts | Transdermal delivery system |
EP3016641B1 (de) | 2013-07-03 | 2018-09-05 | LTS Lohmann Therapie-Systeme AG | Transdermales therapeutisches system mit elektronischem bauteil |
JP6359014B2 (ja) * | 2013-08-21 | 2018-07-18 | 久光製薬株式会社 | 貼付剤 |
USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
US20150182992A1 (en) * | 2013-12-31 | 2015-07-02 | Johnson & Johnson Consumer Companies, Inc. | Process for forming a multilayered shaped film product |
CA2935191C (en) | 2013-12-31 | 2021-11-09 | Johnson & Johnson Consumer Inc. | Process for forming a shaped film product |
US20150325759A1 (en) * | 2014-05-06 | 2015-11-12 | Cree, Inc. | Optical element with integrated indicator |
EP3145504B1 (de) | 2014-05-20 | 2023-07-26 | LTS Lohmann Therapie-Systeme AG | Transdermales abgabesystem mit einem schnittstellenmediator |
JP6895755B2 (ja) | 2014-05-20 | 2021-06-30 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮送達システムにおける活性薬剤の放出を調節するための方法 |
US11633367B2 (en) | 2014-05-20 | 2023-04-25 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system containing rotigotine |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
MX2016013693A (es) | 2014-07-29 | 2017-10-31 | Therapeuticsmd Inc | Crema transdermica. |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
KR101843265B1 (ko) | 2016-06-30 | 2018-03-29 | 서울대학교산학협력단 | 약물 전달 장치 |
US10898450B2 (en) * | 2016-08-25 | 2021-01-26 | Clemtech Pharmaceuticals, LLC | Multi-segmented transdermal dosing unit and methods of use |
KR20190109399A (ko) | 2016-12-05 | 2019-09-25 | 코세어 파마 인코포레이티드 | 트레프로스티닐 및 이의 염의 피부 및 경피 투여 |
JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 経皮薬剤送達の装置及び方法 |
WO2019232077A1 (en) | 2018-05-29 | 2019-12-05 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
WO2020008370A1 (en) * | 2018-07-02 | 2020-01-09 | Clexio Biosciences Ltd. | Transdermal patch |
EP3723740A1 (de) | 2018-10-15 | 2020-10-21 | Vardi, Amnon | Cannabinoide mit langsamer freisetzung und produkte daraus |
US10661065B1 (en) | 2019-02-07 | 2020-05-26 | Neil Brereton Jackson | Systems, devices, and/or methods for managing transdermal patches |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN117337172A (zh) * | 2020-07-06 | 2024-01-02 | 金德瓦药物控释有限公司 | 包括贴片区段的药物递送装置 |
WO2023214209A1 (en) * | 2022-11-26 | 2023-11-09 | Nano Tar Pak | A transdermal patch for delivering a cobalamin vitamin and a fabrication method thereof |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL134681C (de) | 1966-04-26 | |||
US3546141A (en) | 1966-08-08 | 1970-12-08 | Mc Donnell Douglas Corp | Phosphorus-nitrogen polymers and process |
US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4336243A (en) | 1980-08-11 | 1982-06-22 | G. D. Searle & Co. | Transdermal nitroglycerin pad |
US4460372A (en) * | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
US4573996A (en) | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4695464A (en) | 1984-10-09 | 1987-09-22 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4678516A (en) * | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
US4806341A (en) | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
US4751087A (en) | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US4615699A (en) | 1985-05-03 | 1986-10-07 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
US4690683A (en) * | 1985-07-02 | 1987-09-01 | Rutgers, The State University Of New Jersey | Transdermal varapamil delivery device |
US4666441A (en) | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
US5560922A (en) | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
US5006342A (en) * | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
US5023084A (en) | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
US4906169A (en) | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
KR970008118B1 (ko) | 1987-07-09 | 1997-05-21 | 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 | 피부 침투성 치료 시스템 |
US4788064A (en) | 1987-07-31 | 1988-11-29 | Warner-Lambert Company | Transdermal delivery system |
US4943435A (en) | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
US4839174A (en) | 1987-10-05 | 1989-06-13 | Pharmetrix Corporation | Novel transdermal nicotine patch |
US4837027A (en) | 1987-11-09 | 1989-06-06 | Alza Corporation | Transdermal drug delivery device |
US4781924A (en) | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
US4915950A (en) * | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US4840796A (en) | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
US5230701A (en) | 1988-05-13 | 1993-07-27 | Minnesota Mining And Manufacturing Company | Elastomeric adhesive and cohesive materials |
US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
US4908213A (en) | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
US5028435A (en) * | 1989-05-22 | 1991-07-02 | Advanced Polymer Systems, Inc. | System and method for transdermal drug delivery |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
US5240711A (en) | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
SE8904296D0 (sv) | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
GB9111732D0 (en) * | 1991-05-31 | 1991-07-24 | Orion Yhtymae Oy | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs |
CA2090598A1 (en) | 1992-03-04 | 1993-09-05 | Kirti Himatlal Valia | Titratable transdermal patch system and method for administration of therapeutic substances |
US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
CA2075517C (en) | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
DE4223004A1 (de) * | 1992-07-13 | 1994-01-20 | Liedtke Pharmed Gmbh | Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie |
DE4229230C2 (de) | 1992-09-02 | 1997-01-16 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Pentetrazol als Wirkstoff |
DE69333009T2 (de) * | 1992-11-09 | 2003-12-04 | Neurogesx Inc | Transdermale verabreichung von ketorolac |
WO1995006450A1 (en) | 1993-08-31 | 1995-03-09 | Minnesota Mining And Manufacturing Company | Perforated roll of nonwoven surgical tape |
US5466465A (en) * | 1993-12-30 | 1995-11-14 | Harrogate Holdings, Limited | Transdermal drug delivery system |
FR2728463A1 (fr) | 1994-12-21 | 1996-06-28 | Lhd Lab Hygiene Dietetique | Systeme transdermique d'administration simultanee de plusieurs principes actifs |
US5616337A (en) * | 1995-01-30 | 1997-04-01 | Genta Incorporated | Unit dose skin care package |
JPH0982402A (ja) | 1995-09-07 | 1997-03-28 | Yazaki Corp | シールパッキン及び機器直付けコネクタ |
US5902603A (en) | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
US5736154A (en) | 1996-03-11 | 1998-04-07 | Fuisz Technologies Ltd. | Transdermal delivery system |
US6007837A (en) | 1996-07-03 | 1999-12-28 | Alza Corporation | Drug delivery devices and process of manufacture |
JPH1036265A (ja) | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | ブプレノルフィン経皮吸収製剤 |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5879701A (en) | 1997-02-28 | 1999-03-09 | Cygnus, Inc. | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
US6018092A (en) | 1997-03-04 | 2000-01-25 | 3M Innovative Properties Company | Medical adhesive bandage, delivery system and method |
DE19746191C2 (de) | 1997-10-18 | 2000-05-18 | Lohmann Therapie Syst Lts | Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht |
US6475514B1 (en) * | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
DE19900645C2 (de) | 1999-01-11 | 2003-03-20 | Deotexis Inc | Transdermales therapeutisches System |
US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
US6054120A (en) * | 1999-10-08 | 2000-04-25 | Burgoyne; Bradley C. | Sunscreen applicator system |
US6221384B1 (en) * | 1999-11-05 | 2001-04-24 | Anthony C. Pagedas | Segmented transdermal dosage unit |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
ME00114B (me) * | 2003-10-28 | 2011-02-10 | Noven Pharma | Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka |
-
2000
- 2000-11-16 US US09/714,604 patent/US6682757B1/en not_active Expired - Lifetime
-
2001
- 2001-11-13 DK DK01988490T patent/DK1333818T3/da active
- 2001-11-13 EP EP10178119.3A patent/EP2269595B1/de not_active Expired - Lifetime
- 2001-11-13 DK DK08165952.6T patent/DK2002826T3/da active
- 2001-11-13 PT PT01988490T patent/PT1333818E/pt unknown
- 2001-11-13 AU AU2002241792A patent/AU2002241792A1/en not_active Abandoned
- 2001-11-13 ES ES01988490T patent/ES2313995T3/es not_active Expired - Lifetime
- 2001-11-13 ES ES08165952T patent/ES2392697T3/es not_active Expired - Lifetime
- 2001-11-13 EP EP01988490A patent/EP1333818B1/de not_active Expired - Lifetime
- 2001-11-13 PT PT08165952T patent/PT2002826E/pt unknown
- 2001-11-13 DE DE60136087T patent/DE60136087D1/de not_active Expired - Lifetime
- 2001-11-13 AT AT01988490T patent/ATE410153T1/de active
- 2001-11-13 WO PCT/US2001/051197 patent/WO2002041878A2/en active Application Filing
- 2001-11-13 JP JP2002544057A patent/JP5021150B2/ja not_active Expired - Fee Related
- 2001-11-13 EP EP08165952A patent/EP2002826B1/de not_active Expired - Lifetime
-
2003
- 2003-10-20 US US10/690,384 patent/US20040081685A1/en not_active Abandoned
-
2009
- 2009-01-08 CY CY20091100012T patent/CY1108687T1/el unknown
-
2010
- 2010-01-29 JP JP2010018105A patent/JP5501782B2/ja not_active Expired - Fee Related
- 2010-09-30 US US12/894,512 patent/US8784880B2/en not_active Expired - Fee Related
-
2012
- 2012-11-05 CY CY20121101052T patent/CY1116758T1/el unknown
-
2013
- 2013-03-07 JP JP2013045128A patent/JP5721761B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-19 US US14/309,569 patent/US9289397B2/en not_active Expired - Lifetime
- 2014-10-08 JP JP2014207463A patent/JP5977791B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2002241792A1 (en) | 2002-06-03 |
ATE410153T1 (de) | 2008-10-15 |
JP2015028071A (ja) | 2015-02-12 |
US8784880B2 (en) | 2014-07-22 |
JP2004521085A (ja) | 2004-07-15 |
CY1116758T1 (el) | 2017-03-15 |
ES2392697T3 (es) | 2012-12-13 |
EP2002826A1 (de) | 2008-12-17 |
PT1333818E (pt) | 2009-01-14 |
JP5977791B2 (ja) | 2016-08-24 |
JP2010143938A (ja) | 2010-07-01 |
EP1333818A2 (de) | 2003-08-13 |
US6682757B1 (en) | 2004-01-27 |
EP2002826B1 (de) | 2012-08-15 |
DK1333818T3 (da) | 2009-02-02 |
US20140303571A1 (en) | 2014-10-09 |
US20040081685A1 (en) | 2004-04-29 |
EP2269595B1 (de) | 2018-01-31 |
EP2269595A1 (de) | 2011-01-05 |
US20110020450A1 (en) | 2011-01-27 |
DK2002826T3 (da) | 2012-11-26 |
PT2002826E (pt) | 2012-11-21 |
WO2002041878A2 (en) | 2002-05-30 |
JP5501782B2 (ja) | 2014-05-28 |
WO2002041878A3 (en) | 2003-03-13 |
US9289397B2 (en) | 2016-03-22 |
JP2013151521A (ja) | 2013-08-08 |
JP5721761B2 (ja) | 2015-05-20 |
JP5021150B2 (ja) | 2012-09-05 |
EP1333818B1 (de) | 2008-10-08 |
CY1108687T1 (el) | 2014-04-09 |
ES2313995T3 (es) | 2009-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE410153T1 (de) | Transdermales verabreichungssystem mit individueller dosierung | |
Schug et al. | Fentanyl formulations in the management of pain: an update | |
Madhav et al. | Orotransmucosal drug delivery systems: a review | |
AU707003B1 (en) | Method and kit for positioning a transdermal delivery system | |
AU707933B2 (en) | Transdermal delivery system | |
DE69030095T2 (de) | Vorrichtung zum verabreichen von medikamenten auf schleimhautgewebe | |
Vielvoye-Kerkmeer et al. | Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine | |
CA2366785A1 (en) | Soluble tumor necrosis factor receptor treatment of medical disorders | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
NO171950C (no) | Fremgangsmaate for fremstilling av et klebende lag for vedvarende transdermal administrasjon av et farmasoeytisk aktivt legemiddel | |
PT932388E (pt) | Forma de dosagem e metodo para administracao de farmacos | |
ES2194025T3 (es) | Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares. | |
US20220142953A1 (en) | Lidocaine patch and methods of use thereof | |
Fischer et al. | Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat | |
Daly et al. | Randomised controlled trial of a microneedle patch with a topical anaesthetic for relieving the pain of dental injections | |
Citron et al. | Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use | |
RU2005126819A (ru) | Усовершенствованное лечение опухолей | |
O'Neil et al. | Preliminary clinical use of a patient-controlled intranasal analgesia (PCINA) device | |
Yousef et al. | The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study | |
AR003979A1 (es) | Administracion transdermica de vorozol. | |
Wilkie | Cancer pain management: State-of-the-art nursing care | |
Yunmbam et al. | The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo. | |
RU2539418C1 (ru) | Способ лечения местно-распространенного рака орофарингеальной зоны | |
CN102727466B (zh) | 可贴在创伤皮肤表面的风湿膏 | |
ZO et al. | An Overview on Buccal Drug Delivery System |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |